906329-30-4 Usage
General Description
1-BOC-4-CYANO-4-BENZYL-PIPERIDINE is a chemical compound that consists of a piperidine ring with a benzyl group and a cyano group attached to it. The compound also contains a BOC (tert-butoxycarbonyl) protecting group. It is commonly used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. The BOC group protects the amine functionality, allowing for selective reactions with other functional groups. The cyano group, on the other hand, can participate in various chemical reactions such as nucleophilic addition and substitution. The benzyl group also plays a role in the reactivity and stability of the molecule. Overall, 1-BOC-4-CYANO-4-BENZYL-PIPERIDINE is a versatile compound with important applications in organic and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 906329-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,3,2 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 906329-30:
(8*9)+(7*0)+(6*6)+(5*3)+(4*2)+(3*9)+(2*3)+(1*0)=164
164 % 10 = 4
So 906329-30-4 is a valid CAS Registry Number.
906329-30-4Relevant articles and documents
COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
-
Paragraph 0174, (2020/12/11)
Described herein are compounds that act as CYP46A1 inhibitors, compositions comprising these compounds, and methods of their use into treating neurodegenerative diseases and the like, or a pharmaceutically active salt thereof. The present invention relates to compounds represented by the formula wherein each symbol is as defined in the specification, or a pharmaceutically active salt thereof.
HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF
-
Paragraph 0326; 0327; 0328, (2013/05/09)
The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, and the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.